Editorial: Novel immune markers and predictive models for immunotherapy and prognosis in breast and gynecological cancers
Fuhao Wang,
Qingyu Huang,
Shicheng Guo,
Alberto Traverso,
Alberto Traverso,
Feifei Teng,
Chao Liu
Affiliations
Fuhao Wang
Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
Qingyu Huang
Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
Shicheng Guo
Department of Medical Genetics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States
Alberto Traverso
Department of Radiation Oncology (Maastro Clinic), School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, Netherlands
Alberto Traverso
School of Medicine, Libera Università Vita-Salute San Raffaele, Milan, Italy
Feifei Teng
Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
Chao Liu
Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China